These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11649042)

  • 1. Rules to protect drug-test participants via follow-up exams are slated by FDA.
    Spivak J
    Wall St J (East Ed); 1976 Mar; ():5. PubMed ID: 11649042
    [No Abstract]   [Full Text] [Related]  

  • 2. Protecting human research subjects and the public: the role of FDA disqualification of clinical investigators.
    Nightingale SL
    Food Drug Cosmet Law J; 1980 Sep; 35(9):484-92. PubMed ID: 11661914
    [No Abstract]   [Full Text] [Related]  

  • 3. Perspectives on the FDA status of drug products manufactured by the recombinant DNA technique.
    Korwek EL; Trinker DS
    Food Drug Cosmet Law J; 1981 Oct; 36(10):517-35. PubMed ID: 11650658
    [No Abstract]   [Full Text] [Related]  

  • 4. Mandating research with children.
    Baylis F
    IRB; 1999; 21(1):10-1. PubMed ID: 11657966
    [No Abstract]   [Full Text] [Related]  

  • 5. The regulation of clinical investigators.
    Endries RN
    Food Drug Cosmet Law J; 1980 Jul; 35(7):415-23. PubMed ID: 11661860
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental drugs: more of them, but they're no longer free.
    Caplan J
    Hastings Cent Rep; 1987 Jun; 17(3):3. PubMed ID: 11644019
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccination for AIDS: legal and ethical challenges from the test tube, to the human subject, through to the marketplace.
    Gostin L
    AIDS Public Policy J; 1987; 2(2):9-16. PubMed ID: 11650032
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA treatment use regulations: a compassionate response.
    Weitzman SA; Marcy T
    AIDS Public Policy J; 1987; 2(2):22-32. PubMed ID: 11650028
    [No Abstract]   [Full Text] [Related]  

  • 9. The Food and Drug Administration's role in the protection of human subjects.
    Nightingale SL
    IRB; 1983; 5(1):6-9. PubMed ID: 11649511
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical and psychological experimentation on California prisoners.
    Herch F; Flower R
    Univ Calif Davis Law Rev; 1974; 7():351-84. PubMed ID: 11661107
    [No Abstract]   [Full Text] [Related]  

  • 11. The concept of the IRB and bureaucratic reality: an exchange of letters.
    van Eys J; Levine RJ
    IRB; 1984; 6(4):8-10. PubMed ID: 11649563
    [No Abstract]   [Full Text] [Related]  

  • 12. Resolution: RU 486.
    American Association for the Advancement of Science
    Science; 1991 Apr; 252(5005):587. PubMed ID: 11642875
    [No Abstract]   [Full Text] [Related]  

  • 13. AIDS treatment drugs: clinical trials and compassionate use.
    Levine RJ
    AIDS Public Policy J; 1987; 2(2):6-8. PubMed ID: 11650031
    [No Abstract]   [Full Text] [Related]  

  • 14. Military medical research: 2. Proving the safety and effectiveness of a nerve gas antidote -- a legal view.
    Cooper RM
    IRB; 1989; 11(4):7-9. PubMed ID: 11650245
    [No Abstract]   [Full Text] [Related]  

  • 15. Court tells jury to ignore human subject protection regulations.
    Maloney DM
    Hum Res Rep; 1995 Mar; 10(3):4-5. PubMed ID: 11654195
    [No Abstract]   [Full Text] [Related]  

  • 16. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
    Kobasic DM
    J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
    [No Abstract]   [Full Text] [Related]  

  • 17. International research agreement leads to new U.S. guidelines.
    Maloney DM
    Hum Res Rep; 1995 Apr; 10(4):1-2. PubMed ID: 11654182
    [No Abstract]   [Full Text] [Related]  

  • 18. RU 486 and the politics of drug regulation in the United States and France.
    Kramnick RK
    Cornell Int Law J; 1992; 25():667-718. PubMed ID: 11656340
    [No Abstract]   [Full Text] [Related]  

  • 19. Implications of the federal drug investigation and approval processes for the development and availability of AIDS treatments and vaccines.
    Mathers PR
    AIDS Public Policy J; 1987; 2(2):50-3. PubMed ID: 11650030
    [No Abstract]   [Full Text] [Related]  

  • 20. Twice wrong on AIDS.
    Gieringer D
    N Y Times Web; 1987 Jan; ():A21. PubMed ID: 11646161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.